- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$2.89 BnMarket Estimate, 2026
$3.11 BnMarket Forecast, 2034
$5.65 BnCAGR, 2026–2034
7.76%Executive Summary: Europe Veterinary Diagnostics Market
- Market Scope: Comprehensive market evaluation of the European veterinary diagnostics ecosystem, analyzing product categories, companion and food-producing animal segments, and country-level adoption frameworks.
- Market Valuation: Valued at USD 2.89 billion in 2025, estimated at USD 3.11 billion in 2026, and projected to reach USD 5.65 billion by 2034, registering a solid CAGR of 7.76% (2026–2034).
- Primary Growth Drivers: Rising prevalence of zoonotic and infectious animal diseases, expanding pet ownership and per capita expenditure on companion animals, strict European regulations regarding food safety and animal welfare, and growing demand for animal protein.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (Base Position) | Fastest-Growing Segment (2026–2034) |
|---|---|---|
| By Product Type | Immunodiagnostics & Clinical Chemistry (dominate routine testing workflows and in-clinic analyzers) | Molecular Diagnostics (experiencing high expansion driven by demand for precise pathogen identification and genetic screening) |
| By Animal | Companion Animals (canine and feline diagnostics account for the largest revenue share due to high pet insurance adoption and care spending) | Food-Producing / Livestock Animals (growing steadily via stringent government disease surveillance and food safety regulations) |
| By Country / Region | United Kingdom & Germany (lead the European market share through extensive pet care expenditure and mature livestock health infrastructure) | France, Italy, Spain, and Rest of Europe (expanding rapidly via rising animal healthcare awareness and veterinary clinic networks) |
Major Market Players & Market Structure
Market Structure: A competitive and highly regulated medical technology landscape featuring major global diagnostics manufacturers, specialized animal health corporations, and established veterinary reference laboratories.
Key Companies: IDEXX Laboratories Inc., VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer Inc.
Europe Veterinary Diagnostics Market Size
The Europe veterinary diagnostics market size was valued at USD 2.89 billion in 2025 and is anticipated to reach USD 3.11 billion in 2026 from USD 5.65 billion by 2034, growing at a CAGR of 7.76% during the forecast period from 2026 to 2034.

The European Parliament and the Council adopted the Regulation on transmissible animal diseases (“Animal Health Law”) in March 2016. The regulation will be applicable in the next five years. It’ll support the EU livestock sector in its quest for competitiveness and a safe and smooth EU market of animals and their products, creating growth for the veterinary diagnostics market. Veterinary diagnostic products are as complex as they are challenging to manufacture. Many of the poultry and livestock diagnostic products are biological products that demand materials from living organisms. Market development for companion animal diagnostics has depended heavily upon the purchasing and use of in-clinic analyzers or diagnostic instruments used at veterinary practices.
Factors such as growing Zoonotic diseases in animals, increasing the number of veterinary practitioners in Europe, and increasing the demand for animal protein are primarily driving the veterinary diagnostics market in Europe. Growing technological support to diagnose animal diseases, increasing product launches, and rising partnerships between major companies are propelling market growth. In addition, rising per capita income in Europe, growing awareness among pet owners regarding their pet animal’s health, and an increasing number of in-clinical diagnostic methods are forecasted to boost the market.
The high costs associated with veterinary diagnostics and the restorative steps for animal diseases are expected to restrain the market.
The European veterinary diagnostics market accounted for the second-largest share of the global market in 2023. It is further predicted to be growing at a robust CAGR during the forecast period. The UK market for veterinary diagnostics is projected to account for the accounting largest share of the European market during the forecast period due to the growing expenditure on pets. Increasing importance of preventing and control zoonotic animal diseases straight away from the human population across Europe and growing demand for pet insurance, an increasing number of veterinary clinics are driving the market. The German veterinary diagnostics market is forecasted to grow at a healthy rate during the forecast period due to rising animal healthcare expenditure, growing pet adoption, and increasing demand for animal-derived food products. Other countries such as France, Italy, and Spain are expected to have a considerable share during the forecast period.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 7.76% |
| Segments Covered | By Product, Animals and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, the Netherlands, Turkey, and the Czech Republic |
| Market Leaders Profiled | VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, IDEXX Laboratories Inc., Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer |
KEY MARKET PLAYERS
A few noteworthy companies operating in the European veterinary diagnostics market include
- VCA Inc.
- Heska Corporation
- Abaxis Inc.
- VIRBAC
- IDEXX Laboratories Inc.
- Life Technologies Corporation
- Bio-Rad Laboratories Inc.
- Prionics AG
- Pfizer Inc.
MARKET SEGMENTATION
This research report on the European veterinary diagnostics market has been segmented and sub-segmented into the following categories.
By Product Type
- Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Diagnostic Imaging
- Immunodiagnostics
By Animals
- Companion Animals
- Canine Diagnostics
- Feline Diagnostics
- Other Veterinary Diagnostics
- Food-Producing Animals
- Bovine Diagnostics
- Porcine Diagnostics
- Ovine Diagnostics
- Poultry Diagnostics
- Piscine Diagnostics
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe